These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 457275)

  • 21. Modification of reticuloendothelial function by muramyl dipeptide-encapsulated liposomes in jaundiced rats treated with biliary decompression.
    Ding JW; Andersson R; Hultberg B; Soltesz V; Bengmark S
    Scand J Gastroenterol; 1993 Jan; 28(1):53-62. PubMed ID: 8430273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
    Leclerc C; Bourgeois E; Chedid L
    Immunol Commun; 1979; 8(1):55-64. PubMed ID: 311334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H; Koga T
    Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of methyl esterification of isoglutamine residue in 6-O-acylated muramyl dipeptides on expression of immunopharmacological activities.
    Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Kiso M; Hasegawa A; Nomoto K
    Int J Immunopharmacol; 1991; 13(5):573-7. PubMed ID: 1783471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of synthetic muramyl dipeptide (MDP) on differentition of myeloid leukemic cells.
    Akagawa KS; Tokunaga T
    Microbiol Immunol; 1980; 24(10):1005-11. PubMed ID: 6936604
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muramyl dipeptide stimulation of particle clearance in several animal species.
    Waters RV; Ferraresi RW
    J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
    [No Abstract]   [Full Text] [Related]  

  • 30. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
    Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
    Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation.
    Galelli A; Chedid L
    Infect Immun; 1983 Dec; 42(3):1081-5. PubMed ID: 6605930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.
    Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I
    Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
    Kishimoto T
    Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
    [No Abstract]   [Full Text] [Related]  

  • 34. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
    Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
    J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muramyl peptides as possible endogenous immunopharmacological mediators.
    Chedid L
    Microbiol Immunol; 1983; 27(9):723-32. PubMed ID: 6358804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
    Dinarello CA; Elin RJ; Chedid L; Wolff SM
    J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological study of local skin injected with adjuvant-active and -inactive muramyl dipeptide (MDP) (histological change in MDP injected skin.
    Okuyama H; Kobayashi S; Azuma I
    Asian Pac J Allergy Immunol; 1983 Dec; 1(2):89-96. PubMed ID: 6681013
    [No Abstract]   [Full Text] [Related]  

  • 39. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
    Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
    Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
    [No Abstract]   [Full Text] [Related]  

  • 40. Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.
    Tanaka A; Nagao S; Imai K; Mori R
    Microbiol Immunol; 1980; 24(6):547-57. PubMed ID: 7412595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.